Characterization of AβpN3 deposition in the brains of dogs of various ages and other animal species

References

• Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 1985;82:4245–4249.
   PubMed Web of Science ®Google Scholar
• Selkoe DJ. The molecular pathology of Alzheimer's disease. Neuron 1991;6:487–498.
   PubMed Web of Science ®Google Scholar
• Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, Tsopelas ND, Ziolko SK, James JA, Snitz BE, Houck PR, et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol 2008;65:1509–1517.
   PubMed Web of Science ®Google Scholar
• Armstrong RA, Cairns NJ, Myers D, Smith CU, Lantos PL, Rossor MN. A comparison of beta-amyloid deposition in the medial temporal lobe in sporadic Alzheimer's disease, Down's syndrome and normal elderly brains. Neurodegeneration 1996;5:35–41.
   PubMedGoogle Scholar
• Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, et al. Mild cognitive impairment. Lancet 2006;367:1262–1270.
   PubMed Web of Science ®Google Scholar
• Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999;56:303–308.
   PubMed Web of Science ®Google Scholar
• Czasch S, Paul S, Baumgartner W. A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain. Neurobiol Aging 2006;27:293–305.
   PubMed Web of Science ®Google Scholar
• Shimada A, Kuwamura M, Umemura T, Takada K, Ohama E, Itakura C. Modified bielschowsky and immunohistochemical studies on senile plaques in aged dogs. Neurosci Lett 1991;129:25–28.
   PubMed Web of Science ®Google Scholar
• Uchida K, Nakayama H, Goto N. Pathological studies on cerebral amyloid angiopathy, senile plaques and amyloid deposition in visceral organs in aged dogs. J Vet Med Sci 1991;53:1037–1042.
   PubMed Web of Science ®Google Scholar
• Brellou G, Vlemmas I, Lekkas S, Papaioannou N. Immunohistochemical investigation of amyloid beta-protein (abeta) in the brain of aged cats. Histol Histopathol 2005;20:725–731.
   PubMed Web of Science ®Google Scholar
• Nakamura S, Nakayama H, Kiatipattanasakul W, Uetsuka K, Uchida K, Goto N. Senile plaques in very aged cats. Acta Neuropathol 1996;91:437–439.
   PubMed Web of Science ®Google Scholar
• Nakamura S, Nakayama H, Goto N, Ono-Ochikubo F, Sakakibara I, Yoshikawa Y. Histopathological studies on senile plaques and cerebral amyloid angiopathy in aged cynomolgus monkeys. Exp Anim 1995;43:711–718.
   PubMed Web of Science ®Google Scholar
• Struble RG, Price DL Jr, Cork LC, Price DL. Senile plaques in cortex of aged normal monkeys. Brain Res 1985;361:267–275.
   PubMed Web of Science ®Google Scholar
• Walker LC, Masters C, Beyreuther K, Price DL. Amyloid in the brains of aged squirrel monkeys. Acta Neuropathol 1990;80:381–387.
   PubMed Web of Science ®Google Scholar
• Wisniewski HM, Ghetti B, Terry RD. Neuritic (senile) plaques and filamentous changes in aged rhesus monkeys. J Neuropathol Exp Neurol 1973;32:566–584.
   PubMed Web of Science ®Google Scholar
• Cork LC, Powers RE, Selkoe DJ, Davies P, Geyer JJ, Price DL. Neurofibrillary tangles and senile plaques in aged bears. J Neuropathol Exp Neurol 1988;47:629–641.
   PubMed Web of Science ®Google Scholar
• Uchida K, Yoshino T, Yamaguchi R, Tateyama S, Kimoto Y, Nakayama H, Goto N. Senile plaques and other senile changes in the brain of an aged american black bear. Vet Pathol 1995;32:412–414.
   PubMed Web of Science ®Google Scholar
• Roertgen KE, Parisi JE, Clark HB, Barnes DL, O'Brien TD, Johnson KH. A beta-associated cerebral angiopathy and senile plaques with neurofibrillary tangles and cerebral hemorrhage in an aged wolverine (gulo gulo). Neurobiol Aging 1996;17: 243–247.
   PubMed Web of Science ®Google Scholar
• Nakamura S, Nakayama H, Uetsuka K, Sasaki N, Uchida K, Goto N. Senile plaques in an aged two-humped (bactrian) camel (camelus bactrianus). Acta Neuropathol 1995;90:415–418.
   PubMed Web of Science ®Google Scholar
• Nakayama H, Katayama K, Ikawa A, Miyawaki K, Shinozuka J, Uetsuka K, Nakamura S, Kimura N, Yoshikawa Y, Doi K. Cerebral amyloid angiopathy in an aged great spotted woodpecker (picoides major). Neurobiol Aging 1999;20:53–56.
   PubMed Web of Science ®Google Scholar
• Papaioannou N, Tooten PCJ, van Ederen AM, Bohl JRE, Rofina J, Tsangaris T, Gruys E. Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques. Amyloid 2001;8:11–21.
   PubMed Web of Science ®Google Scholar
• Rofina J, van Andel I, van Ederen AM, Papaioannou N, Yamaguchi H, Gruys E. Canine counterpart of senile dementia of the Alzheimer type: amyloid plaques near capillaries but lack of spatial relationship with activated microglia and macrophages. Amyloid 2003;10:86–96.
   PubMed Web of Science ®Google Scholar
• Rofina JE, Singh K, Skoumalova-Vesela A, van Ederen AM, van Asten AJAM, Wilhelm J, Gruys E. Histochemical accumulation of oxidative damage products is associated with Alzheimer-like pathology in the canine. Amyloid 2004;11:90–100.
   PubMed Web of Science ®Google Scholar
• Janus C, Westaway D. Transgenic mouse models of Alzheimer's disease. Physiol Behav 2001;73:873–886.
   PubMed Web of Science ®Google Scholar
• Wisniewski T, Sigurdsson EM. Murine models of Alzheimer's disease and their use in developing immunotherapies. Biochim Biophys Acta 2010;1802:847–859.
   PubMed Web of Science ®Google Scholar
• Philipson O, Lord A, Gumucio A, O'Callaghan P, Lannfelt L, Nilsson LN. Animal models of amyloid-beta-related pathologies in Alzheimer's disease. FEBS J 2010;277:1389–1409.
   PubMed Web of Science ®Google Scholar
• Sarasa M, Pesini P. Natural non-trasgenic animal models for research in Alzheimer's disease. Curr Alzheimer Res 2009;6:171–178.
   PubMed Web of Science ®Google Scholar
• Head E, McCleary R, Hahn FF, Milgram NW, Cotman CW. Region-specific age at onset of beta-amyloid in dogs. Neurobiol Aging 2000;21:89–96.
   PubMed Web of Science ®Google Scholar
• Cummings BJ, Head E, Ruehl W, Milgram NW, Cotman CW. The canine as an animal model of human aging and dementia. Neurobiol Aging 1996;17:259–268.
   PubMed Web of Science ®Google Scholar
• Nakayama H, Uchida K, Doi K. A comparative study of age-related brain pathology–are neurodegenerative diseases present in nonhuman animals? Med Hypotheses 2004;63:198–202.
   PubMed Web of Science ®Google Scholar
• Pugliese M, Mascort J, Mahy N, Ferrer I. Diffuse beta-amyloid plaques and hyperphosphorylated tau are unrelated processes in aged dogs with behavioral deficits. Acta Neuropathol 2006;112:175–183.
   PubMed Web of Science ®Google Scholar
• Saido TC, Yamao-Harigaya W, Iwatsubo T, Kawashima S. Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain. Neurosci Lett 1996;215: 173–176.
   PubMed Web of Science ®Google Scholar
• Fukumoto H, Asami-Odaka A, Suzuki N, Shimada H, Ihara Y, Iwatsubo T. Amyloid beta protein deposition in normal aging has the same characteristics as that in Alzheimer's disease. predominance of A beta 42(43) and association of A beta 40 with cored plaques. Am J Pathol 1996;148:259–265.
   PubMed Web of Science ®Google Scholar
• Piccini A, Russo C, Gliozzi A, Relini A, Vitali A, Borghi R, Giliberto L, Armirotti A, D'Arrigo C, Bachi A, et al. Beta-amyloid is different in normal aging and in Alzheimer disease. J Biol Chem 2005;280:34186–34192.
   PubMed Web of Science ®Google Scholar
• Schilling S, Zeitschel U, Hoffmann T, Heiser U, Francke M, Kehlen A, Holzer M, Hutter-Paier B, Prokesch M, Windisch M, et al. Glutaminyl cyclase inhibition attenuates pyroglutamate abeta and Alzheimer's disease-like pathology. Nat Med 2008;14:1106–1111.
   PubMed Web of Science ®Google Scholar
• Gunn AP, Masters CL, Cherny RA. Pyroglutamate-abeta: Role in the natural history of Alzheimer's disease. Int J Biochem Cell Biol 2010;42:1915–1918.
   PubMed Web of Science ®Google Scholar
• Marcello A, Wirths O, Schneider-Axmann T, Degerman-Gunnarsson M, Lannfelt L, Bayer TA. Reduced levels of IgM autoantibodies against N-truncated pyroglutamate abeta in plasma of patients with Alzheimer's disease Neurobiol Aging, in press
   Google Scholar
• Reeves RH. Down's syndrome. A complicated genetic insult. Lancet 2001;358: Suppl:S23.
   Google Scholar
• Russo C, Saido TC, DeBusk LM, Tabaton M, Gambetti P, Teller JK. Heterogeneity of water-soluble amyloid beta-peptide in Alzheimer's disease and down's syndrome brains. FEBS Lett 1997;409:411–416.
   PubMed Web of Science ®Google Scholar
• Yoshino T, Uchida K, Tateyama S, Yamaguchi R, Nakayama H, Goto N. A retrospective study of canine senile plaques and cerebral amyloid angiopathy. Vet Pathol 1996;33:230–234.
   PubMed Web of Science ®Google Scholar
• Portelius E, Bogdanovic N, Gustavsson MK, Volkmann I, Brinkmalm G, Zetterberg H, Winblad B, Blennow K. Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease. Acta Neuropathol 2010;120:185–193.
   PubMed Web of Science ®Google Scholar
• Tekirian TL. Commentary: Abeta N-terminal isoforms: Critical contributors in the course of AD pathophysiology. J Alzheimers Dis 2001;3:241–248.
   PubMed Web of Science ®Google Scholar
• Johnstone EM, Chaney MO, Norris FH, Pascual R, Little SP. Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. Brain Res Mol Brain Res 1991;10:299–305.
   PubMedGoogle Scholar
• Selkoe DJ, Bell DS, Podlisny MB, Price DL, Cork LC. Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science 1987;235:873–877.
   PubMed Web of Science ®Google Scholar
• Schilling S, Appl T, Hoffmann T, Cynis H, Schulz K, Jagla W, Friedrich D, Wermann M, Buchholz M, Heiser U, et al. Inhibition of glutaminyl cyclase prevents pGlu-abeta formation after intracortical/hippocampal microinjection in vivo/in situ. J Neurochem 2008;106:1225–1236.
   PubMed Web of Science ®Google Scholar
• Pohl T, Zimmer M, Mugele K, Spiess J. Primary structure and functional expression of a glutaminyl cyclase. Proc Natl Acad Sci USA 1991;88:10059–10063.
   PubMed Web of Science ®Google Scholar
• Schilling S, Wasternack C, Demuth HU. Glutaminyl cyclases from animals and plants: A case of functionally convergent protein evolution. Biol Chem 2008;389: 983–991.
   PubMed Web of Science ®Google Scholar
• Stephan A, Wermann M, von Bohlen A, Koch B, Cynis H, Demuth HU, Schilling S. Mammalian glutaminyl cyclases and their isoenzymes have identical enzymatic characteristics. FEBS J 2009;276:6522–6536.
   PubMed Web of Science ®Google Scholar
• Sykes PA, Watson SJ, Temple JS, Bateman RC Jr.Evidence for tissue-specific forms of glutaminyl cyclase. FEBS Lett 1999;455:159–161.
   PubMed Web of Science ®Google Scholar
• Hartig W, Goldhammer S, Bauer U, Wegner F, Wirths O, Bayer TA, Grosche J. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice. J Chem Neuroanat 2010;40:82–92.
   PubMed Web of Science ®Google Scholar
• He W, Barrow CJ. The A beta 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater beta-sheet forming and aggregation propensities in vitro than full-length A beta. Biochemistry 1999;38:10871–10877.
   PubMed Web of Science ®Google Scholar
• Sanders HM, Lust R, Teller JK. Amyloid-beta peptide Abetap3-42 affects early aggregation of full-length Abeta1-42. Peptides 2009;30:849–854.
   PubMed Web of Science ®Google Scholar
• Citron M. Strategies for disease modification in Alzheimer's disease. Nat Rev Neurosci 2004;5:677–685.
   PubMed Web of Science ®Google Scholar
• Solomon B. Alzheimer's disease and immunotherapy. Curr Alzheimer Res 2004;1:149–163.
   PubMed Web of Science ®Google Scholar
• Bard F, Barbour R, Cannon C, Carretto R, Fox M, Games D, Guido T, Hoenow K, Hu K, Johnson-Wood K, et al. Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology. Proc Natl Acad Sci USA 2003;100:2023–2028.
   PubMed Web of Science ®Google Scholar
• Solomon B, Koppel R, Frankel D, Hanan-Aharon E. Disaggregation of Alzheimer beta-amyloid by site-directed mAb. Proc Natl Acad Sci USA 1997;94:4109–4112.
   PubMed Web of Science ®Google Scholar
• Acero G, Manoutcharian K, Vasilevko V, Munguia ME, Govezensky T, Coronas G, Luz-Madrigal A, Cribbs DH, Gevorkian G. Immunodominant epitope and properties of pyroglutamate-modified abeta-specific antibodies produced in rabbits. J Neuroimmunol 2009;213:39–46.
   PubMed Web of Science ®Google Scholar
• Britschgi M, Olin CE, Johns HT, Takeda-Uchimura Y, LeMieux MC, Rufibach K, Rajadas J, Zhang H, Tomooka B, Robinson WH, et al. Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease. Proc Natl Acad Sci USA 2009;106:12145–12150.
   PubMed Web of Science ®Google Scholar
• Frenkel D, Katz O, Solomon B. Immunization against Alzheimer's beta-amyloid plaques via EFRH phage administration. Proc Natl Acad Sci USA 2000;97:11455–11459.
   PubMed Web of Science ®Google Scholar
• Head E, Pop V, Vasilevko V, Hill M, Saing T, Sarsoza F, Nistor M, Christie LA, Milton S, Glabe C, et al. A two-year study with fibrillar beta-amyloid (abeta) immunization in aged canines: Effects on cognitive function and brain abeta. J Neurosci 2008;28:3555–3566.
   PubMed Web of Science ®Google Scholar
• Bernedo V, Insua D, Suarez ML, Santamarina G, Sarasa M, Pesini P. Beta-amyloid cortical deposits are accompanied by the loss of serotonergic neurons in the dog. J Comp Neurol 2009;513:417–429.
   PubMed Web of Science ®Google Scholar
• Cummings BJ, Head E, Afagh AJ, Milgram NW, Cotman CW. Beta-amyloid accumulation correlates with cognitive dysfunction in the aged canine. Neurobiol Learn Mem 1996;66:11–23.
   PubMed Web of Science ®Google Scholar
• Head E, Callahan H, Muggenburg BA, Cotman CW, Milgram NW. Visual-discrimination learning ability and beta-amyloid accumulation in the dog. Neurobiol Aging 1998;19:415–425.
   PubMed Web of Science ®Google Scholar
• Rofina JE, van Ederen AM, Toussaint MJM, Secreve M, van der Spek A, van der Meer I, van Eerdenburg FJCM, Gruys E. Cognitive disturbances in old dogs suffering from the canine counterpart of Alzheimer's disease. Brain Res 2006;1069: 216–226.
   PubMed Web of Science ®Google Scholar
• Tapp PD, Siwak CT, Estrada J, Head E, Muggenburg BA, Cotman CW, Milgram NW. Size and reversal learning in the beagle dog as a measure of executive function and inhibitory control in aging. Learn Mem 2003;10:64–73.
   PubMed Web of Science ®Google Scholar
• Tapp PD, Siwak CT, Estrada J, Holowachuk D, Milgram NW. Effects of age on measures of complex working memory span in the beagle dog (canis familiaris) using two versions of a spatial list learning paradigm. Learn Mem 2003;10:148–160.
   PubMed Web of Science ®Google Scholar
• Russo C, Violani E, Salis S, Venezia V, Dolcini V, Damonte G, Benatti U, D'Arrigo C, Patrone E, Carlo P, et al. Pyroglutamate-modified amyloid beta-peptides–AbetaN3 (pE)–strongly affect cultured neuron and astrocyte survival. J Neurochem 2002;82:1480–1489.
   PubMed Web of Science ®Google Scholar
• Wirths O, Breyhan H, Cynis H, Schilling S, Demuth HU, Bayer TA. Intraneuronal pyroglutamate-abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model. Acta Neuropathol 2009;118:487–496.
   PubMed Web of Science ®Google Scholar
• Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE. Cerebral amyloid angiopathy: Amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol 1998;153: 725–733.
   PubMed Web of Science ®Google Scholar
• Vanderstichele H, De Meyer G, Andreasen N, Kostanjevecki V, Wallin A, Olsson A, Blennow K, Vanmechelen E. Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment. Clin Chem 2005;51:1650–1660.
   PubMed Web of Science ®Google Scholar